The Current Ratio as of November 2024 (TTM) for Prenetics Global Limited (PRE) is 2.06

According to Prenetics Global Limited’s latest financial reports and current stock price. The company's current Current Ratio is 2.06. This represents a change of -7.92% compared to the average of 2.23 of the last 4 quarters.

Prenetics Global Limited (PRE) Historical Current Ratio (quarterly & annually)

How has PRE Current Ratio performed in the past?

The mean historical Current Ratio of Prenetics Global Limited over the last ten years is 2.09. The current 2.06 Current Ratio has changed 9.72% with respect to the historical average. Over the past ten years (40 quarters), PRE's Current Ratio was at its highest in in the September 2022 quarter at 5.05. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Prenetics Global Limited (PRE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Prenetics Global Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Prenetics Global Limited (PRE) Average Current Ratio

How has PRE Current Ratio performed in the past?

The current Current Ratio of Prenetics Global Limited (PRE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Prenetics Global Limited (PRE) Current Ratio vs. Peers

How is PRE’s Current Ratio compared to its peers?

Prenetics Global Limited’s Current Ratio is less than Neogen Corporation (4.41), greater than Qiagen N.V. (1.77), less than Olink Holding AB (publ) (5.60), less than Aclaris Therapeutics, Inc. (7.50), greater than Syneos Health, Inc. (1.20), less than FONAR Corporation (7.86), less than Burning Rock Biotech Limited (3.11), less than Sera Prognostics, Inc. (2.08), greater than LumiraDx Limited (1.97), greater than Genetron Holdings Limited (1.82), less than Biodesix, Inc. (3.40), less than Castle Biosciences, Inc. (8.12), greater than MDxHealth SA (0.91), greater than Inotiv, Inc. (0.31), less than DarioHealth Corp. (2.26), less than Exagen Inc. (4.32),

Build a custom stock screener for Prenetics Global Limited (PRE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prenetics Global Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Prenetics Global Limited (PRE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Prenetics Global Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.